Peptide Therapy Cost: Full Pricing Breakdown by Type (2026)

Overview

Peptide therapy has grown from a niche biohacking interest into a mainstream medical category spanning weight management, hormone optimization, tissue repair, cognitive enhancement, and anti-aging. As demand has surged, so has the complexity of pricing across different peptides, providers, and delivery models. Costs vary dramatically depending on whether you are using an FDA-approved brand-name product through a traditional healthcare system, a compounded peptide through a telehealth platform, or sourcing research-grade material independently. Provider fees, required lab work, injection supplies, and follow-up consultations add layers of cost that are not always transparent upfront. This guide provides a comprehensive breakdown of peptide therapy pricing across every major category in 2026, compares telehealth versus in-person clinic models, examines the reality of insurance coverage, and identifies concrete strategies to reduce your total out-of-pocket expense. All pricing reflects current US market rates and should be used as general guidance rather than exact quotes, as costs vary by provider, region, and individual treatment plans. This content is for educational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy.

Average Cost Ranges by Peptide Category

Peptide therapy costs vary enormously depending on the category of peptide prescribed. GLP-1 receptor agonists for weight loss represent the most expensive tier, with brand-name semaglutide (Wegovy) costing approximately $1,349 per month and tirzepatide (Zepbound) at approximately $1,060 per month at wholesale acquisition cost. Compounded versions of these GLP-1 medications, available through 503A and 503B pharmacies during active FDA shortage periods, typically range from $200 to $500 per month. Growth hormone secretagogues such as CJC-1295 with DAC, ipamorelin, sermorelin, and tesamorelin occupy the mid-range tier. Compounded sermorelin generally costs $150 to $350 per month, while CJC-1295/ipamorelin combination protocols run $200 to $450 per month depending on dosing frequency and source. Tesamorelin (Egrifta), the only FDA-approved GHRH analog, costs approximately $800 to $1,200 per month at brand-name pricing but is typically covered for its FDA-approved indication in HIV-associated lipodystrophy. MK-677 (ibutamoren), an oral growth hormone secretagogue, is available through research chemical suppliers at $50 to $100 per month, though it lacks FDA approval. Healing and recovery peptides such as BPC-157 and TB-500 (thymosin beta-4 fragment) are among the most affordable compounded peptides, typically ranging from $100 to $300 per month depending on the protocol and provider. Nootropic and neuroprotective peptides including Semax, Selank, and Dihexa are generally priced at $75 to $250 per month. Sexual health peptides like PT-141 (bremelanotide) cost approximately $50 to $150 per dose in compounded form, with the brand-name Vyleesi priced significantly higher. Anti-aging peptides such as epithalon and GHK-Cu range from $100 to $300 per month in compounded formulations. The total monthly investment depends heavily on whether patients are using single peptides or stacking multiple compounds.

• GLP-1 agonists (brand-name): $935-$1,349/month; compounded: $200-$500/month
• Growth hormone secretagogues (sermorelin, CJC-1295/ipamorelin): $150-$450/month compounded
• Tesamorelin (Egrifta, brand-name): $800-$1,200/month; may be covered for HIV lipodystrophy
• Healing peptides (BPC-157, TB-500): $100-$300/month compounded
• Nootropic peptides (Semax, Selank, Dihexa): $75-$250/month
• Sexual health (PT-141 compounded): $50-$150/dose; Vyleesi brand: ~$900/dose
• Anti-aging (epithalon, GHK-Cu): $100-$300/month compounded
• MK-677 (oral, research-grade): $50-$100/month; not FDA-approved

Telehealth vs In-Person Clinic Pricing

The delivery model you choose for peptide therapy significantly impacts total cost, convenience, and clinical oversight. Traditional in-person clinics — including anti-aging practices, functional medicine offices, and hormone optimization centers — typically charge higher consultation fees but may provide more comprehensive physical examinations, in-house lab draws, and hands-on injection training. Initial consultation fees at brick-and-mortar peptide clinics range from $200 to $500, with follow-up visits costing $100 to $300 every 4 to 12 weeks. Many clinics add a markup to the peptides themselves, purchasing compounded medications at wholesale and reselling at retail margins of 30% to 100% or more. Total monthly costs at premium anti-aging clinics can reach $500 to $1,500 when combining consultation fees, peptide costs, lab work, and supplies. Telehealth peptide platforms have disrupted this model by offering lower overhead, streamlined onboarding, and bundled pricing. Major telehealth providers in the peptide therapy space typically charge $99 to $299 per month for all-inclusive plans that cover physician consultations, the peptides themselves, shipping, and basic supplies. Some platforms charge a flat monthly membership fee plus per-medication costs, while others bundle everything into a single subscription. The telehealth model generally offers 30% to 50% savings compared to in-person clinics, though the trade-off is reduced face-to-face interaction and potentially less personalized monitoring. Hybrid models are emerging where initial consultations occur in person with ongoing management via telehealth, attempting to combine the benefits of both approaches. Regardless of the model, patients should verify that their provider employs licensed physicians, uses accredited compounding pharmacies with proper 503A or 503B registration, and includes appropriate lab monitoring in the treatment plan.

• In-person clinic initial consultation: $200-$500; follow-ups: $100-$300 every 4-12 weeks
• In-person clinics often mark up peptide costs 30-100% above wholesale compounding prices
• Premium anti-aging clinics total cost: $500-$1,500/month including all services and medications
• Telehealth platforms: $99-$299/month for bundled plans (consultation + peptides + shipping)
• Telehealth generally offers 30-50% savings compared to in-person clinics
• Hybrid models combine in-person initial evaluation with ongoing telehealth management
• Verify any provider uses licensed physicians and accredited compounding pharmacies (503A/503B)

Insurance Coverage Reality for Peptide Therapy

The vast majority of peptide therapy is not covered by health insurance, and patients should budget accordingly. Insurance coverage exists only for a narrow subset of FDA-approved peptide medications prescribed for their approved indications. Semaglutide (Ozempic) is covered by most commercial plans for type 2 diabetes, and Wegovy coverage for obesity is expanding but remains inconsistent. Tirzepatide (Mounjaro) has diabetes coverage, and Zepbound has growing but variable obesity coverage. Tesamorelin (Egrifta) is typically covered for HIV-associated lipodystrophy. Bremelanotide (Vyleesi) has limited coverage for hypoactive sexual desire disorder in premenopausal women, though prior authorization requirements and formulary restrictions are common. Beyond these specific cases, peptide therapy is classified as elective, experimental, or off-label by insurers, placing the full financial burden on the patient. Growth hormone secretagogues like sermorelin, CJC-1295, and ipamorelin are not FDA-approved and are exclusively self-pay. Healing peptides like BPC-157 and TB-500 have no FDA-approved indication and receive zero insurance coverage. Anti-aging and nootropic peptides are similarly excluded. Even when a peptide is FDA-approved, off-label use is rarely covered — for example, using tesamorelin for general fat loss rather than HIV lipodystrophy will not be reimbursed. Some patients use Health Savings Accounts (HSAs) or Flexible Spending Accounts (FSAs) to pay for peptide therapy with pre-tax dollars, though eligibility depends on whether the treatment is prescribed by a licensed physician for a documented medical condition. Patients should obtain a letter of medical necessity from their provider if they plan to use HSA or FSA funds for peptide therapy, as this may be required for reimbursement or audit purposes.

• FDA-approved peptides with insurance coverage: semaglutide (diabetes/obesity), tirzepatide (diabetes/obesity), tesamorelin (HIV lipodystrophy), bremelanotide (HSDD)
• Compounded peptides (BPC-157, TB-500, sermorelin, CJC-1295, ipamorelin): zero insurance coverage — 100% self-pay
• Off-label use of FDA-approved peptides is rarely covered by insurance
• HSA and FSA accounts may be used for peptide therapy if prescribed for a documented medical condition
• Obtain a letter of medical necessity from your provider to support HSA/FSA reimbursement claims
• Medicare and Medicaid generally do not cover peptide therapy except for specific FDA-approved indications

Compounding Pharmacy vs Brand-Name Pricing

The distinction between compounded and brand-name peptides represents the single largest pricing variable in peptide therapy. Brand-name FDA-approved products undergo rigorous clinical development costing hundreds of millions of dollars, manufacture under current Good Manufacturing Practice (cGMP) standards, carry full prescribing information with documented efficacy and safety data, and are sold at prices reflecting these investments. Compounded peptides are produced by compounding pharmacies under Section 503A (patient-specific prescriptions) or Section 503B (outsourcing facilities) of the Federal Food, Drug, and Cosmetic Act. Compounding pharmacies can legally produce copies of commercially available drugs during FDA-designated shortages or create formulations that are not commercially available, and they price their products dramatically lower because they do not bear clinical trial costs. The price differential is substantial: brand-name semaglutide costs $935 to $1,349 per month versus $200 to $500 compounded; brand-name tesamorelin (Egrifta) runs $800 to $1,200 versus $200 to $400 compounded. For peptides without any FDA-approved brand-name equivalent — such as BPC-157, TB-500, CJC-1295, and ipamorelin — compounding pharmacies are the only legitimate source, and pricing is determined by manufacturing costs, peptide synthesis complexity, and competitive market dynamics. However, lower cost comes with trade-offs in regulatory oversight and quality assurance. Compounded peptides are not FDA-approved, not tested for bioequivalence, and may vary in potency and purity between batches. Patients should verify their compounding pharmacy is registered with the FDA and their state board of pharmacy, request certificates of analysis for each batch, confirm the pharmacy follows USP 797 and USP 800 compounding standards, and ask about third-party testing protocols. Not all compounding pharmacies are equal, and selecting a reputable source is critical to safety and efficacy.

• Brand-name semaglutide: $935-$1,349/month vs compounded: $200-$500/month
• Brand-name tesamorelin (Egrifta): $800-$1,200/month vs compounded: $200-$400/month
• Peptides without brand-name equivalents (BPC-157, TB-500, CJC-1295): only available compounded at $100-$400/month
• Compounded peptides are not FDA-approved and may vary in potency and purity between batches
• Verify pharmacy holds 503A or 503B registration and provides batch-specific certificates of analysis
• USP 797 sterile compounding standards and third-party testing are markers of a reputable compounding pharmacy

Hidden Costs: Supplies, Labs, and Follow-Up Visits

The sticker price of a peptide vial or prescription represents only part of the total cost of peptide therapy. Several additional expenses are frequently overlooked when budgeting for treatment. Injection supplies including insulin syringes, alcohol swabs, sharps containers, and bacteriostatic water for reconstitution typically add $15 to $40 per month depending on injection frequency and sourcing. Patients on multiple injectable peptides may need separate syringes for each injection, increasing supply costs. Bacteriostatic water, required for reconstituting lyophilized peptide powders, costs $5 to $15 per 30 mL vial and may last one to several months depending on the number of peptides being reconstituted. Laboratory testing represents a significant recurring cost that many patients underestimate. Baseline labs before starting peptide therapy commonly include a comprehensive metabolic panel, complete blood count, lipid panel, fasting insulin, HbA1c, IGF-1, testosterone panel (for men), thyroid panel, and sometimes specialized markers like liver enzymes and inflammatory markers. Initial lab panels typically cost $200 to $600 through a provider or $75 to $200 through direct-to-consumer lab services like Quest or Labcorp self-order. Follow-up labs every 8 to 12 weeks can cost $100 to $400 per round, and most responsible peptide therapy protocols require at least quarterly monitoring during the first year. Provider follow-up visits, whether in person or via telehealth, add $50 to $300 per visit depending on the practice model. Some clinics require monthly check-ins during the initial stabilization period, adding $600 to $3,600 annually in consultation fees alone. Shipping costs for compounded peptides requiring cold-chain transport (overnight or two-day with ice packs) can add $20 to $50 per shipment. When calculating the true monthly cost of peptide therapy, patients should add 20% to 40% to the medication cost to account for supplies, labs, consultations, and shipping.

• Injection supplies (syringes, swabs, sharps container): $15-$40/month
• Bacteriostatic water for reconstitution: $5-$15 per 30 mL vial
• Baseline lab panel: $200-$600 through a provider; $75-$200 via direct-to-consumer services
• Follow-up labs every 8-12 weeks: $100-$400 per round
• Provider follow-up visits: $50-$300 each, typically monthly to quarterly
• Cold-chain shipping for peptides: $20-$50 per shipment
• Rule of thumb: add 20-40% to medication cost to estimate true monthly expense

Cost Comparison Across Peptide Categories

Understanding how peptide therapy costs compare across categories helps patients prioritize their investment and set realistic budgets. GLP-1 receptor agonists for weight loss are by far the most expensive category, reflecting their blockbuster commercial status and massive demand. At brand-name pricing, semaglutide (Wegovy) runs approximately $1,349 per month and tirzepatide (Zepbound) approximately $1,060 per month. Compounded GLP-1 alternatives during active FDA shortages range from $200 to $500 per month. Growth hormone peptide stacks represent the second-highest cost tier. A typical CJC-1295/ipamorelin protocol costs $200 to $450 per month compounded, while sermorelin runs $150 to $350 per month. Adding MK-677 orally can supplement GH output for an additional $50 to $100 per month. Tesamorelin at brand-name pricing ($800 to $1,200) is expensive, but compounded versions are more accessible at $200 to $400. Healing and recovery peptides are among the most affordable options. BPC-157 typically costs $100 to $250 per month, and TB-500 ranges from $150 to $300. A combined BPC-157/TB-500 healing stack can often be sourced for $200 to $400 per month. These peptides are commonly used in time-limited protocols (4 to 12 weeks) rather than indefinitely, reducing total treatment cost. Nootropic and immune peptides including Semax ($75 to $200/month), Selank ($75 to $200/month), thymosin alpha-1 ($200 to $400/month), and GHK-Cu ($100 to $250/month) occupy the low-to-mid price range. Sexual health peptides like compounded PT-141 cost $50 to $150 per dose and are used on-demand rather than daily, making per-month costs highly variable. Anti-aging protocols combining multiple peptides (such as epithalon with GHK-Cu and a GH secretagogue) can reach $400 to $800 per month for the full stack.

• GLP-1 weight loss (brand): $935-$1,349/month — highest cost category
• GLP-1 weight loss (compounded): $200-$500/month during FDA shortages
• GH secretagogue stacks (CJC-1295/ipamorelin): $200-$450/month compounded
• Healing stack (BPC-157 + TB-500): $200-$400/month, typically time-limited 4-12 week protocols
• Nootropics (Semax, Selank): $75-$200/month each
• Sexual health (PT-141, on-demand): $50-$150/dose, variable monthly cost
• Full anti-aging stacks (multiple peptides): $400-$800/month

How to Reduce Your Peptide Therapy Costs

Several practical strategies can meaningfully reduce the total cost of peptide therapy without compromising safety or efficacy. First, use manufacturer savings programs for FDA-approved peptides. Novo Nordisk offers savings cards for Wegovy and Ozempic that can reduce copays to as low as $0 to $25 per month for commercially insured patients. Eli Lilly offers similar programs for Mounjaro and Zepbound. These programs are available to patients with commercial insurance and can dramatically reduce out-of-pocket costs for GLP-1 therapy. Second, compare pricing across multiple telehealth platforms and compounding pharmacies. Prices for the same compounded peptide can vary by 50% to 100% between providers, and many platforms offer introductory pricing, multi-month discounts, or loyalty programs. Third, use direct-to-consumer lab services for monitoring. Services like Quest Direct, Labcorp OnDemand, and online platforms offering discounted lab panels can reduce monitoring costs by 50% to 75% compared to ordering through a provider office. Fourth, buy supplies in bulk. Purchasing insulin syringes, alcohol swabs, and bacteriostatic water in larger quantities from medical supply retailers reduces per-unit costs significantly. Fifth, consider time-limited protocols where appropriate. Healing peptides like BPC-157 and TB-500 are typically used in defined cycles rather than indefinitely, and some GH secretagogue protocols incorporate cycling to reduce annual cost. Sixth, explore HSA and FSA eligibility for pre-tax savings of 20% to 35% depending on your marginal tax rate. Seventh, ask your provider about dose optimization — using the minimum effective dose rather than maximum doses can reduce medication costs while maintaining therapeutic benefit. Finally, look for multi-peptide compounding discounts, as some pharmacies offer reduced pricing when multiple peptides are ordered together or combined into a single vial where clinically appropriate.

• Activate manufacturer savings cards for FDA-approved peptides (Wegovy, Ozempic, Mounjaro, Zepbound): copays as low as $0-$25/month
• Compare pricing across 3-5 telehealth platforms and compounding pharmacies — price differences of 50-100% are common
• Use direct-to-consumer lab services (Quest Direct, Labcorp OnDemand) to reduce monitoring costs by 50-75%
• Buy injection supplies in bulk from medical supply retailers for significant per-unit savings
• Use time-limited protocols for healing peptides (4-12 week cycles) rather than indefinite treatment
• Leverage HSA/FSA accounts for pre-tax savings of 20-35% on prescribed peptide therapy
• Discuss dose optimization with your provider — minimum effective dosing reduces cost while maintaining results
• Ask about multi-peptide compounding discounts for combination protocols

References

1. Cost-effectiveness of semaglutide 2.4 mg for the treatment of adult patients with overweight and obesity in the United States (2022) — PubMed
2. Economic burden of obesity and overweight in the United States: trends and projections (2021) — PubMed
3. Compounding pharmacies and the role of 503A and 503B facilities in drug manufacturing (2025)
4. Growth hormone secretagogues: clinical applications and cost considerations in anti-aging medicine (2019) — PubMed
5. Insurance coverage and access to anti-obesity medications in the United States (2023) — PubMed